In this study, the EP procedure was used in order to develop a simple mouse model of DUX4 local expression in skeletal muscle, with the end purpose of rapid therapeutic testing for FSHD. This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.